Guardian Wealth Advisors LLC NC Purchases 52 Shares of Elevance Health, Inc. (NYSE:ELV)

Guardian Wealth Advisors LLC NC increased its stake in shares of Elevance Health, Inc. (NYSE:ELV) by 7.7% during the fourth quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The firm owned 723 shares of the company’s stock after acquiring an additional 52 shares during the period. Guardian Wealth Advisors LLC NC’s holdings in Elevance Health were worth $267,000 as of its most recent SEC filing.

A number of other hedge funds and other institutional investors have also made changes to their positions in ELV. Gotham Asset Management LLC boosted its stake in shares of Elevance Health by 101.4% during the 4th quarter. Gotham Asset Management LLC now owns 53,686 shares of the company’s stock worth $19,805,000 after buying an additional 27,033 shares during the last quarter. EdgePoint Investment Group Inc. grew its holdings in shares of Elevance Health by 22.0% in the 4th quarter. EdgePoint Investment Group Inc. now owns 1,601,517 shares of the company’s stock valued at $590,800,000 after acquiring an additional 288,825 shares in the last quarter. Ethic Inc. grew its holdings in shares of Elevance Health by 28.9% in the 4th quarter. Ethic Inc. now owns 24,399 shares of the company’s stock valued at $9,001,000 after acquiring an additional 5,471 shares in the last quarter. Eschler Asset Management LLP bought a new position in shares of Elevance Health in the 4th quarter valued at about $1,089,000. Finally, First Manhattan CO. LLC. grew its holdings in shares of Elevance Health by 293.3% in the 4th quarter. First Manhattan CO. LLC. now owns 4,712 shares of the company’s stock valued at $1,738,000 after acquiring an additional 3,514 shares in the last quarter. 89.24% of the stock is currently owned by institutional investors and hedge funds.

Wall Street Analyst Weigh In

Several equities analysts have recently weighed in on the company. Royal Bank of Canada restated an “outperform” rating and issued a $478.00 price objective on shares of Elevance Health in a report on Wednesday, April 23rd. Robert W. Baird reissued a “neutral” rating and set a $529.00 price target (down previously from $625.00) on shares of Elevance Health in a research report on Tuesday, April 15th. Sanford C. Bernstein reissued an “outperform” rating on shares of Elevance Health in a research report on Friday, March 28th. Barclays boosted their price target on Elevance Health from $512.00 to $522.00 and gave the stock an “overweight” rating in a research report on Wednesday, April 23rd. Finally, Guggenheim reissued a “buy” rating and set a $518.00 price target on shares of Elevance Health in a research report on Wednesday, April 23rd. Four investment analysts have rated the stock with a hold rating and fourteen have given a buy rating to the stock. Based on data from MarketBeat.com, Elevance Health currently has a consensus rating of “Moderate Buy” and a consensus target price of $510.38.

Elevance Health Stock Down 1.9%

Shares of ELV opened at $404.52 on Monday. Elevance Health, Inc. has a one year low of $362.21 and a one year high of $567.26. The company has a market cap of $91.40 billion, a P/E ratio of 15.80, a P/E/G ratio of 1.18 and a beta of 0.66. The company has a debt-to-equity ratio of 0.71, a current ratio of 1.45 and a quick ratio of 1.50. The firm has a 50 day simple moving average of $424.13 and a two-hundred day simple moving average of $404.41.

Elevance Health (NYSE:ELV) last announced its quarterly earnings data on Tuesday, April 22nd. The company reported $11.97 EPS for the quarter, beating the consensus estimate of $10.60 by $1.37. Elevance Health had a net margin of 3.38% and a return on equity of 18.28%. The business had revenue of $48.77 billion during the quarter, compared to the consensus estimate of $46.26 billion. Research analysts forecast that Elevance Health, Inc. will post 33.96 EPS for the current fiscal year.

Elevance Health Announces Dividend

The company also recently disclosed a quarterly dividend, which will be paid on Wednesday, June 25th. Shareholders of record on Tuesday, June 10th will be given a dividend of $1.71 per share. The ex-dividend date of this dividend is Tuesday, June 10th. This represents a $6.84 annualized dividend and a yield of 1.69%. Elevance Health’s dividend payout ratio is currently 26.69%.

Insider Buying and Selling at Elevance Health

In other news, EVP Charles Morgan Kendrick, Jr. sold 3,504 shares of the company’s stock in a transaction on Wednesday, March 5th. The shares were sold at an average price of $396.30, for a total transaction of $1,388,635.20. Following the completion of the transaction, the executive vice president now directly owns 10,116 shares in the company, valued at approximately $4,008,970.80. This represents a 25.73% decrease in their ownership of the stock. The sale was disclosed in a filing with the Securities & Exchange Commission, which is accessible through the SEC website. Also, CAO Ronald W. Penczek sold 443 shares of the company’s stock in a transaction on Monday, March 10th. The stock was sold at an average price of $415.13, for a total transaction of $183,902.59. Following the transaction, the chief accounting officer now owns 1,847 shares of the company’s stock, valued at $766,745.11. This trade represents a 19.34% decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders sold a total of 8,535 shares of company stock worth $3,521,612 over the last three months. Corporate insiders own 0.29% of the company’s stock.

About Elevance Health

Elevance Health, Inc, together with its subsidiaries, operates as a health benefits company in the United States. The company operates through four segments: Health Benefits, CarelonRx, Carelon Services, and Corporate & Other. It offers a variety of health plans and services to program members; health products; an array of fee-based administrative managed care services; and specialty and other insurance products and services, such as stop loss, dental, vision, life, disability, and supplemental health insurance benefits.